Anna Sureda
0000-0002-1238-6970
8 papers found
Refreshing results…
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation
Is Post-Transplant Cyclophosphamide the New Methotrexate?
Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
Missing publications? Search for publications with a matching author name.